CP-944629 Chemische Eigenschaften,Einsatz,Produktion Methoden

Biochem/physiol Actions

CP-9446219 is a potent p38alpha (p38α) inhibitor (IC50 = 1.8 nM) with no inhibitory potency against a panel of 26 other knases (IC50 >10 μM), including p38gamma (p38γ) and p38delta (p38δ), MKK1, MAPK2/ERK2, JNK, MAPKAP-K1a, and MAPKAP-K2. CP-944629 effectively inhibits LPS-stimulated cellular TNF-α production in vitro (IC50 = 63 and 8.3 nM, using human whole blood and isolated mononuclear cells, respectively) and in rats in vivo (ED50 = 0.1 mg/kg p.o.) with good pharmacokinetic profile and oral availability (F = 66%/monkey, 54%/rat).

CP-944629 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

CP-944629 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	32161	58
TargetMol Chemicals Inc.	+8613564774135	zijue.cai@tsbiochem.com	United States	19885	58
Sigma-Aldrich	021-61415566 800-8193336	orderCN@merckgroup.com	China	51456	80
Energy Chemical	021-58432009 400-005-6266	marketing@energy-chemical.com	China	44918	58
Beijing Biocreative Technology Co., Ltd.	15522676233	3007606172@qq.com	China	1248	58
TargetMol Chemicals Inc.	15002134094	marketing@targetmol.cn	China	19704	58

---

• CP-944629
• 1,2,4-Triazolo[4,3-a]pyridine, 3-(1,1-dimethylethyl)-6-[4-(2,4,5-trifluorophenyl)-5-oxazolyl]-
• CP-944629 >=98% (HPLC)
• 668990-94-1